Health Care & Life Sciences » Biotechnology | Beijing SL Pharmaceutical Co. Ltd.

Beijing SL Pharmaceutical Co. Ltd. A | Ownership

Companies that own Beijing SL Pharmaceutical Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
China Investment Corp. (Investment Management)
8,024,100
1.42%
0
0.12%
09/30/2017
Zhong Ou Asset Management Co., Ltd
4,917,700
0.87%
0
0.47%
09/30/2017
Yinhua Fund Management Co., Ltd.
4,917,700
0.87%
0
0.41%
09/30/2017
Da Cheng Fund Management Co., Ltd.
4,917,700
0.87%
0
0.55%
09/30/2017
China Asset Management Co., Ltd.
4,917,700
0.87%
0
0.13%
09/30/2017
China Southern Asset Management Co., Ltd.
1,831,653
0.32%
-501,386
0.08%
12/31/2017
Guotai Asset Management Co., Ltd.
1,151,951
0.2%
-767,335
0.09%
12/31/2017
Huashang Fund Management Co., Ltd.
910,174
0.16%
-1,696,536
0.19%
12/31/2017
China Merchants Fund Management Co., Ltd.
729,769
0.13%
-63,300
0.09%
12/31/2017
Bosera Asset Management Co., Ltd.
600,050
0.11%
600,050
0.03%
12/31/2017

About Beijing SL Pharmaceutical Co.

View Profile
Address
Building 1, Bitong Park
Beijing Beijing 100143
China
Employees -
Website http://www.slpharm.com.cn
Updated 07/08/2019
Beijing SL Pharmaceutical Co., Ltd. engages in the development of new drugs. Its products include anti-tumor tablets, liver tablets; cardiovascular and osteoporosis medication, recombinant products, small volume injection, freeze-dried powder, capsules, granules, and pharmaceutical raw materials. The company was founded in December 1994 and is headquartered in Beijing, China.